TERMINATION AND SHARE CANCELLATION AGREEMENTTermination And • July 12th, 2018 • HypGen Inc • Pharmaceutical preparations
This Termination and Share Cancellation Agreement (the “Agreement”) is entered into as of July 5, 2018 (the “Effective Date”) by and between HypGen, Inc. (formerly, Mega Bridge, Inc.), a Nevada corporation (the “Company”), and Brighton Capital, Ltd., with primary address at 1875 Century Park East Suite 700, Los Angeles, California 90067 (the “Consultant”), with reference to the following:
TERMINATION AND SHARE CANCELLATION AGREEMENTTermination And • July 12th, 2018 • HypGen Inc • Pharmaceutical preparations
This Termination and Share Cancellation Agreement (the “Agreement”) is entered into as of July 4, 2018 (the “Effective Date”) by and between HypGen, Inc. (formerly, Mega Bridge, Inc.), a Nevada corporation (the “Company”), and Rafferty Finances, S.A., with primary address at Pasea Estate, Tortola, Road Town, VI (the “Consultant”), with reference to the following:
CANCELLATION AGREEMENTCancellation Agreement • July 12th, 2018 • HypGen Inc • Pharmaceutical preparations • Nevada
This Cancellation Agreement, dated July 5, 2018 (this "Agreement"), is made and entered into by and among HypGen, Inc., a Nevada corporation (the "Company"), and certain shareholders of the Company which are named on the signature page to this Agreement (together, the "Canceling Parties"), with respect to the following facts:
WARRANT AMENDMENT AGREEMENTWarrant Amendment Agreement • July 12th, 2018 • HypGen Inc • Pharmaceutical preparations • Nevada
This Warrant Amendment Agreement, dated July 9, 2018 (this "Agreement"), is made and entered into by and among HypGen, Inc., a Nevada corporation, formerly known as Mega Bridge Inc. (the "Company"), and certain warrant holders of the Company which are named on the signature page to this Agreement (together, the "Amending Parties"), with respect to the following facts:
